SCHEMBL4513102

SCHEMBL4513102

CC(=O)c1ccn(S(=O)(=O)c2ccc(C)cc2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.75
PKM P14618 2/20 0.74
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
GRM4 Q14833 1/20 0.48
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44
TUBA3E Q6PEY2 1/20 0.44
TUBA1A Q71U36 1/20 0.44
TUBA1C Q9BQE3 1/20 0.44
TUBB6 Q9BUF5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL589219 0.87 ALDH1A1 (0.61) ALDH1A1PKMCA1CA2GRM4
SCHEMBL1504624 0.87 PKM (0.60) ALDH1A1PKMCA1CA2GRM4
SCHEMBL1370626 0.86 ALDH1A1 (0.56) ALDH1A1PKMCA1CA2GRM4
Hydrochloric Acid SCHEMBL1891433 0.86 PKM (0.59) ALDH1A1PKMCA1CA2GRM4
SCHEMBL1370629 0.86 ALDH1A1 (0.56) ALDH1A1PKMCA1CA2GRM4
SCHEMBL1366438 0.85 PKM (1.00) ALDH1A1PKMGRM4MAPTTUBB4A
SCHEMBL13545185 0.83 ALDH1A1 (0.54) ALDH1A1PKMCA1CA2GRM4
SCHEMBL13485768 0.83 ALDH1A1 (0.54) ALDH1A1PKMCA1CA2GRM4
SCHEMBL4501807 0.83 FBP1 (0.60) ALDH1A1PKMCA1CA2GRM4
SCHEMBL10037185 0.83 ALDH1A1 (0.54) ALDH1A1PKMCA1CA2GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024064745-A1 SYNTHESIS OF RELDESEMTIV CYTOKINETICS, INCORPORATED (US) 2024-03-28 WO claimed
JP-3205422-A None JP disclosed
EP-4734985-A1 PREVENTION, INHIBITION OR TREATMENT OF CONDITIONS OR DISORDERS MEDIATED BY UROCANATE REDUCTASE IMPLEXION PHARMA AB (SE) 2026-05-06 EP disclosed
US-12391781-B2 Black particles, black coating material, coating film, and black matrix for color filters SEKISUI CHEMICAL CO., LTD. (JP) 2025-08-19 US disclosed
EP-4063426-B1 BLACK PARTICLES, BLACK COATING MATERIAL, COATING FILM, AND BLACK MATRIX FOR COLOR FILTERS SEKISUI CHEMICAL CO LTD (JP) 2025-06-18 EP disclosed
WO-2025003469-A1 PREVENTION, INHIBITION OR TREATMENT OF CONDITIONS OR DISORDERS MEDIATED BY UROCANATE REDUCTASE IMPLEXION PHARMA AB (SE) 2025-01-02 WO disclosed
WO-2024064745-A1 SYNTHESIS OF RELDESEMTIV CYTOKINETICS, INCORPORATED (US) 2024-03-28 WO disclosed
WO-2024064745-A1 SYNTHESIS OF RELDESEMTIV CYTOKINETICS, INCORPORATED (US) 2024-03-28 WO disclosed
CN-114502677-B Black particles, black paint, coating film, and black matrix for color filter 积水化学工业株式会社 2023-11-14 CN disclosed
US-20220411553-A1 BLACK PARTICLES, BLACK COATING MATERIAL, COATING FILM, AND BLACK MATRIX FOR COLOR FILTERS SEKISUI CHEMICAL CO., LTD. (JP) 2022-12-29 US disclosed
US-20060189555-A1 Pyrroles substituted by oligonucleotides APIBIO (FR) 2006-08-24 US disclosed
EP-1578759-A1 PYRROLES SUBSTITUTED BY OLIGONUCLEOTIDES BIOMERIEUX SA (FR) 2005-09-28 EP disclosed
WO-2004060904-A1 PYRROLES SUBSTITUTED BY OLIGONUCLEOTIDES BIOMERIEUX SA (FR) 2004-07-22 WO disclosed
EP-1138048-A1 ELECTRICALLY CONDUCTIVE ELECTROACTIVE FUNCTIONALIZED CONJUGATED POLYMERS, AND USES THEREOF BIO MERIEUX (FR) 2001-10-04 EP disclosed
US-6201086-B1 POLYPYRROLE COVALENTLY BONDED TO A MOLECULE CAPABLE OF BINDING TO BIOLOGICAL MOLECULES OR ANTILIGANDS; USED TO FORM AN ELECTRODE AND IN ASSAYS BIO MERIEUX (FR) 2001-03-13 US disclosed
WO-2000031750-A1 ELECTRICALLY CONDUCTIVE ELECTROACTIVE FUNCTIONALIZED CONJUGATED POLYMERS, AND USES THEREOF BIO MERIEUX (FR) 2000-06-02 WO disclosed
US-5149826-A Poly[(3-pyrrolyl)acetic acid] NIPPON OIL CO., LTD. (JP) 1992-09-22 US disclosed
US-5059694-A 3-SUBSTITUTED POLYPYRROLE NIPPON OIL CO., LTD. (JP) 1991-10-22 US disclosed
JP-H03205422-A POLY((3-PYRROLYL)ACETIC ACID) NIPPON OIL CO LTD 1991-09-06 JP disclosed
EP-0396937-A2 3-Substituted polypyrrole NIPPON OIL CO. LTD. (JP) 1990-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189555-A1 Pyrroles substituted by oligonucleotides POLR2E, NSUN3, RNGTT ALDH1A1 2268/4885PKM 3872/4885CA1 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.